Friday, February 10, 2012 Issue 15   VOLUME 1 ISSUE 15  

ARCHIVE
Issue 14
November 12, 2004
Vol. 1 Issue 14

[MORE]
SEARCH
Search for articles containing:
SUBSCRIBE
Subscribe to
WE MOVE News
FAQs on Off-Time Management Are Available at WEMOVE.ORG
WE MOVE is committed to increasing people’s understanding of the language of Parkinson’s disease, raising health literacy levels, and closing the communication gap between patients and physicians. One step in this regard is the publication of frequently asked questions (FAQs) on the WE MOVE web site.  

[FULL STORY]
 
Are Changes in Heart Valves Associated With the Use of Dopamine-Receptor Agonists?
Several recent publications have identified patients who have developed changes in their heart valves while taking ergot-derived drugs for the treatment of Parkinson’s disease and restless legs syndrome.
[FULL STORY]
 
The 2005 Exploring Spasticity Calendar Has Arrived!
Exploring Spasticity provides information, resources, and support for people living with spasticity and those who care about them. Each year, the program sponsors a contest in which participants submit drawings or essays that highlight the courage it takes to live with spasticity. From these submissions, judges select 12 to illustrate the annual Exploring Spasticity calendar. To order your free copy of the 2005 calendar, visit the Exploring Spasticity web site at http://www.exploringspasticity.com/ or call 1-800-731-2921 today.

 
Exposure to Environmental Toxins and the Risk of Developing Essential Tremor
A team of scientists in New York recently interviewed people with essential tremor and control subjects. They found that exposure at work to manganese or organic solvents did not increase the risk of developing essential tremor.
[FULL STORY]
 
A New Animal Model Sheds Light on the Cause of Parkinson’s Disease
This graphic image of a proteasome is provided by the U.S. Department of Energy’s Genomes to Life Program, http://doegenomestolife.org Researchers in New York and Boston teamed up to develop a new animal model of Parkinson’s disease—one that has all of the key features of the disease and in which the symptoms become worse over time.
[FULL STORY]
 


  WE MOVE News is supported by an educational grant from the Medtronic Foundation.

Published by WE MOVE
Copyright © 2004 WE MOVE. All rights reserved.
TELL A FRIEND


Judith Blazer, Executive Director  
Joy B. Leffler, Director of Education
Cate Murray and Richard Robinson, Medical Editors

Powered by IMN